Separate names with a comma.
Celgene reported better-than-expected first quarter results, as its flagship drug for multiple myeloma continued to increase in new and repeat...
Celgene announces positive results from the trials with its development partners Bluebird Bio and Juno Therapeutics in ASH 2017. I think it's an...